As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
Articles
-
-
Serious physical assault and subsequent risk for rehospitalization in individuals with severe mental illness: a nationwide, register-based retrospective cohort study
-
The use of esketamine in comorbid treatment resistant depression and obsessive compulsive disorder following extensive pharmacogenomic testing: a case report
-
Depression and anxiety symptoms in young adults before and during the COVID-19 pandemic: evidence from a Canadian population-based cohort
-
Long-term oral blonanserin treatment for schizophrenia: a review of Japanese long-term studies
-
A cross-sectional analysis of video games and attention deficit hyperactivity disorder symptoms in adolescents
-
Depression and Obstructive Sleep Apnea (OSA)
-
Guidelines for rating Global Assessment of Functioning (GAF)
-
Hospital Anxiety and Depression Scale (HADS): validation in a Greek general hospital sample
-
Suicide risk in schizophrenia: learning from the past to change the future
Aims and scope
Annals of General Psychiatry considers manuscripts on all aspects of psychiatry, including neuroscience and psychological medicine. Both basic and clinical neuroscience contributions are encouraged.
Annals of General Psychiatry emphasizes a biopsychosocial approach to illness and health and strongly supports and follows the principles of evidence-based medicine. As an open access journal, Annals of General Psychiatry facilitates the worldwide distribution of high quality psychiatry and mental health research. The journal considers submissions on a wide range of topics including, but not limited to, psychopharmacology, forensic psychiatry, psychotic disorders, psychiatric genetics, and mood and anxiety disorders.
Featured article: Dietary total antioxidant capacity is inversely associated with depression, anxiety and some oxidative stress biomarkers in postmenopausal women
"Postmenopausal women are at higher risk of mental disorders. Oxidative stress has implication in the development of these disorders... An inverse relationship was found between dietary total antioxidant capacity (DTAC) with depression, anxiety scores and some oxidative stress biomarkers in postmenopausal women. These findings indicate DTAC may be used for developing effective dietary measures for reducing depression and anxiety in these women."
Affiliated with
-
Official publication of the International Society of Neurobiology and Psychopharmacology.
Annual Journal Metrics
-
Speed
147 days to first decision for reviewed manuscripts only
82 days to first decision for all manuscripts
199 days from submission to acceptance
14 days from acceptance to publicationCitation Impact
3.455 - 2-year Impact Factor
3.410 - 5-year Impact Factor
1.657 - Source Normalized Impact per Paper (SNIP)
1.074 - SCImago Journal Rank (SJR)Usage
554,406 Downloads
252 Altmetric mentions